

[ Wed, Dec 04th 2024
] - Brian Stokes
[ Wed, Dec 04th 2024
] - Brian Stokes
[ Wed, Dec 04th 2024
] - Terrence Williams
[ Wed, Dec 04th 2024
] - Michael Jones
[ Wed, Dec 04th 2024
] - Michael Jones
[ Wed, Dec 04th 2024
] - Michael Jones
[ Wed, Dec 04th 2024
] - Phil Bruner
[ Wed, Dec 04th 2024
] - Phil Bruner
[ Wed, Dec 04th 2024
] - Tim Hastings
[ Wed, Dec 04th 2024
] - Tim Hastings
[ Wed, Dec 04th 2024
] - Tim Hastings
[ Wed, Dec 04th 2024
] - Thomas Matters
[ Wed, Dec 04th 2024
] - Brian Stokes
[ Wed, Dec 04th 2024
] - Michael Jones
[ Wed, Dec 04th 2024
] - Thomas Matters
[ Wed, Dec 04th 2024
] - Bill Williamson
[ Wed, Dec 04th 2024
] - Bill Williamson
[ Wed, Dec 04th 2024
] - Tim Hastings
[ Wed, Dec 04th 2024
] - Thomas Matters
[ Wed, Dec 04th 2024
] - Brian Stokes
[ Wed, Dec 04th 2024
] - Brian Stokes
[ Wed, Dec 04th 2024
] - Michael Jones
[ Wed, Dec 04th 2024
] - Michael Jones
[ Wed, Dec 04th 2024
] - Michael Jones
[ Wed, Dec 04th 2024
] - Phil Bruner
[ Wed, Dec 04th 2024
] - Phil Bruner
[ Wed, Dec 04th 2024
] - Tim Hastings
[ Wed, Dec 04th 2024
] - Tim Hastings
[ Wed, Dec 04th 2024
] - Tim Hastings
[ Wed, Dec 04th 2024
] - Bill Williamson
[ Wed, Dec 04th 2024
] - Brian Stokes
[ Wed, Dec 04th 2024
] - Terrence Williams
[ Wed, Dec 04th 2024
] - Terrence Williams
[ Wed, Dec 04th 2024
] - Michael Jones
[ Wed, Dec 04th 2024
] - Phil Bruner
[ Wed, Dec 04th 2024
] - Bill Williamson
[ Wed, Dec 04th 2024
] - Bill Williamson
[ Wed, Dec 04th 2024
] - Brian Stokes
[ Wed, Dec 04th 2024
] - Terrence Williams
[ Wed, Dec 04th 2024
] - Michael Jones
[ Wed, Dec 04th 2024
] - Phil Bruner
[ Wed, Dec 04th 2024
] - Brian Stokes
[ Wed, Dec 04th 2024
] - Brian Stokes
[ Wed, Dec 04th 2024
] - Michael Jones
[ Wed, Dec 04th 2024
] - Michael Jones
[ Wed, Dec 04th 2024
] - Tim Hastings
[ Wed, Dec 04th 2024
] - Aaron Neefham
[ Wed, Dec 04th 2024
] - Thomas Matters
[ Wed, Dec 04th 2024
] - Brian Stokes
[ Wed, Dec 04th 2024
] - Thomas Matters
[ Wed, Dec 04th 2024
] - Brian Stokes
[ Wed, Dec 04th 2024
] - Brian Stokes
[ Wed, Dec 04th 2024
] - Brian Stokes

[ Tue, Dec 03rd 2024
] - Terrence Williams
[ Tue, Dec 03rd 2024
] - Terrence Williams
[ Tue, Dec 03rd 2024
] - Michael Jones
[ Tue, Dec 03rd 2024
] - Michael Jones
[ Tue, Dec 03rd 2024
] - Phil Bruner
[ Tue, Dec 03rd 2024
] - Phil Bruner
[ Tue, Dec 03rd 2024
] - Phil Bruner
[ Tue, Dec 03rd 2024
] - Tim Hastings
[ Tue, Dec 03rd 2024
] - Tim Hastings
[ Tue, Dec 03rd 2024
] - Thomas Matters
[ Tue, Dec 03rd 2024
] - Aaron Neefham
[ Tue, Dec 03rd 2024
] - Thomas Matters
[ Tue, Dec 03rd 2024
] - Brian Stokes
[ Tue, Dec 03rd 2024
] - Thomas Matters
[ Tue, Dec 03rd 2024
] - Bill Williamson
[ Tue, Dec 03rd 2024
] - Brian Stokes
[ Tue, Dec 03rd 2024
] - Brian Stokes
[ Tue, Dec 03rd 2024
] - Bill Williamson
[ Tue, Dec 03rd 2024
] - Brian Stokes
[ Tue, Dec 03rd 2024
] - Bill Williamson
[ Tue, Dec 03rd 2024
] - Brian Stokes
[ Tue, Dec 03rd 2024
] - Terrence Williams
[ Tue, Dec 03rd 2024
] - Michael Jones
[ Tue, Dec 03rd 2024
] - Thomas Matters
[ Tue, Dec 03rd 2024
] - Brian Stokes
[ Tue, Dec 03rd 2024
] - Terrence Williams
[ Tue, Dec 03rd 2024
] - Terrence Williams
[ Tue, Dec 03rd 2024
] - Terrence Williams
[ Tue, Dec 03rd 2024
] - Michael Jones
[ Tue, Dec 03rd 2024
] - Aaron Neefham
[ Tue, Dec 03rd 2024
] - Brian Stokes
[ Tue, Dec 03rd 2024
] - Brian Stokes
[ Tue, Dec 03rd 2024
] - Terrence Williams
[ Tue, Dec 03rd 2024
] - Aaron Neefham
[ Tue, Dec 03rd 2024
] - Brian Stokes
[ Tue, Dec 03rd 2024
] - Brian Stokes
[ Tue, Dec 03rd 2024
] - Terrence Williams
[ Tue, Dec 03rd 2024
] - Michael Jones
[ Tue, Dec 03rd 2024
] - Michael Jones
[ Tue, Dec 03rd 2024
] - Tim Hastings
[ Tue, Dec 03rd 2024
] - Thomas Matters
[ Tue, Dec 03rd 2024
] - Brian Stokes
[ Tue, Dec 03rd 2024
] - Brian Stokes
[ Tue, Dec 03rd 2024
] - Brian Stokes
[ Tue, Dec 03rd 2024
] - Terrence Williams
[ Tue, Dec 03rd 2024
] - Terrence Williams
[ Tue, Dec 03rd 2024
] - Terrence Williams
[ Tue, Dec 03rd 2024
] - Michael Jones
[ Tue, Dec 03rd 2024
] - Phil Bruner
[ Tue, Dec 03rd 2024
] - Tim Hastings
[ Tue, Dec 03rd 2024
] - Tim Hastings
[ Tue, Dec 03rd 2024
] - Aaron Neefham
[ Tue, Dec 03rd 2024
] - Bill Williamson
[ Tue, Dec 03rd 2024
] - Brian Stokes
[ Tue, Dec 03rd 2024
] - Bill Williamson
[ Tue, Dec 03rd 2024
] - Brian Stokes
[ Tue, Dec 03rd 2024
] - Bill Williamson
[ Tue, Dec 03rd 2024
] - Brian Stokes
[ Tue, Dec 03rd 2024
] - Michael Jones
[ Tue, Dec 03rd 2024
] - Phil Bruner
[ Tue, Dec 03rd 2024
] - Phil Bruner
[ Tue, Dec 03rd 2024
] - Aaron Neefham
[ Tue, Dec 03rd 2024
] - Bill Williamson
[ Tue, Dec 03rd 2024
] - Bill Williamson
[ Tue, Dec 03rd 2024
] - Thomas Matters
[ Tue, Dec 03rd 2024
] - Brian Stokes
[ Tue, Dec 03rd 2024
] - Bill Williamson
[ Tue, Dec 03rd 2024
] - Bill Williamson
[ Tue, Dec 03rd 2024
] - Brian Stokes
[ Tue, Dec 03rd 2024
] - Brian Stokes
[ Tue, Dec 03rd 2024
] - Bill Williamson
[ Tue, Dec 03rd 2024
] - Brian Stokes
[ Tue, Dec 03rd 2024
] - Terrence Williams
[ Tue, Dec 03rd 2024
] - Tim Hastings
[ Tue, Dec 03rd 2024
] - Aaron Neefham
[ Tue, Dec 03rd 2024
] - Brian Stokes
[ Tue, Dec 03rd 2024
] - Thomas Matters
[ Tue, Dec 03rd 2024
] - Brian Stokes
[ Tue, Dec 03rd 2024
] - Brian Stokes
[ Tue, Dec 03rd 2024
] - Brian Stokes
[ Tue, Dec 03rd 2024
] - Brian Stokes
[ Tue, Dec 03rd 2024
] - Brian Stokes
[ Tue, Dec 03rd 2024
] - Terrence Williams
[ Tue, Dec 03rd 2024
] - Phil Bruner
[ Tue, Dec 03rd 2024
] - Tim Hastings
[ Tue, Dec 03rd 2024
] - Tim Hastings
[ Tue, Dec 03rd 2024
] - Tim Hastings
[ Tue, Dec 03rd 2024
] - Thomas Matters
[ Tue, Dec 03rd 2024
] - Brian Stokes
[ Tue, Dec 03rd 2024
] - Brian Stokes
[ Tue, Dec 03rd 2024
] - Tim Hastings
[ Tue, Dec 03rd 2024
] - Brian Stokes
[ Tue, Dec 03rd 2024
] - Bill Williamson
[ Tue, Dec 03rd 2024
] - Brian Stokes
[ Tue, Dec 03rd 2024
] - Terrence Williams
[ Tue, Dec 03rd 2024
] - Terrence Williams
[ Tue, Dec 03rd 2024
] - Michael Jones
[ Tue, Dec 03rd 2024
] - Phil Bruner
[ Tue, Dec 03rd 2024
] - Tim Hastings
2 Disruptive Growth Stocks With Room to Run
- With a Food and Drug Administration (FDA) End-of-Phase 2 meeting scheduled for Q4 and strong efficacy data across its clinical pipeline, Viking represents an intriguing opportunity for investors seeking focused exposure to next-generation metabolic therapeutics.

Read the Full The Motley Fool Article at:
[ https://www.fool.com/investing/2024/12/03/2-disruptive-growth-stocks-with-room-to-run/ ]